Stocklytics Platform
Asset logo for symbol NKTX
Nkarta
NKTX49
$2.35arrow_drop_down6.19%-$0.15
Penny Stock
Asset logo for symbol NKTX
NKTX49

$2.35

arrow_drop_down6.19%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Nkarta (NKTX) Stocklytics Forecast

Nkarta Inc (NKTX) is a biopharmaceutical company that is focused on developing and commercializing cell therapies for the treatment of cancer. The company's innovative approach harnesses the power of natural killer (NK) cells, which are a type of immune cell that can directly kill cancer cells. Nkarta's lead product candidate, NKX101, is being evaluated in clinical trials for the treatment of various types of cancer, including acute myeloid leukemia and non-Hodgkin's lymphoma.
Looking at the stock price prediction for Nkarta Inc (NKTX), it is important to consider both fundamental and technical factors. From a fundamental perspective, the company has a strong pipeline of potential cell therapies and has been making progress in its clinical trials. This could contribute to a positive outlook for the stock in the long term. Additionally, Nkarta Inc has formed partnerships with leading pharmaceutical companies, which could provide further support for its growth prospects.
add Nkarta to watchlist

Keep an eye on Nkarta

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Nkarta (NKTX) stock?

Analysts have set a target price of $20.41 for Nkarta (NKTX), based on forecasts from 22 analysts. The predicted price range extends from a high of $38 to a low of $9. This represents a potential increase of up to 1.52K% and a decrease of 282.98% from the current price of $2.35. These forecasts are as of 2021 Dec 22.
help

What are the analyst ratings for Nkarta (NKTX) stock?

The analyst ratings for Nkarta (NKTX) are distributed as follows: 8 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Nkarta .
help

What is the AI price prediction for Nkarta (NKTX) stock?

At present, there is no AI or machine-learning-based price prediction available for Nkarta (NKTX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level